IceCure Medical Ltd (ICCM) vs Nuwellis, Inc. (NUWE)
A side-by-side comparison of IceCure Medical Ltd and Nuwellis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCM
IceCure Medical Ltd
$1.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NUWE
Nuwellis, Inc.
$0.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ICCM vs NUWE
growth of $100 · dividends reinvested · last 2yICCM -91.9% (-71.6%/yr)NUWE -99.5% (-92.9%/yr)ICCM compounded faster over this window
Log scale — wide-divergence pair
ICCM NUWE
ICCM vs NUWE: by the numbers
- •ICCM is the larger company ($3M vs $3M market cap).
- •Both run net losses; NUWE's is the smaller (-123.38% vs -427.67% net margin).
- •NUWE grew revenue faster over the past five years (1.48% vs -0.69% CAGR).
Metrics side by side
Valuation
| Metric | ICCM | NUWE |
|---|---|---|
| P/S ratio | 0.72 | 0.28 |
| P/B ratio | 0.24 | N/A |
Profitability
| Metric | ICCM | NUWE |
|---|---|---|
| Gross margin | 36.10% | 69.69% |
| Operating margin | -446.70% | -140.62% |
| Net margin | -427.67% | -123.38% |
| ROE | -141.90% | N/A |
| ROIC | -184.27% | -238.32% |
Growth (annualized)
| Metric | ICCM | NUWE |
|---|---|---|
| Revenue CAGR (5Y) | -0.69% | 1.48% |
| Total return CAGR (5Y) | -63.05% | N/A |
Frequently asked
- Which has grown faster, ICCM or NUWE?
- Over the past five years, NUWE grew revenue faster — ICCM at a -0.69% CAGR versus NUWE at 1.48%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.